< > W170 - Centers for Disease Control and Prevention (CDC) - http://www.cdc.gov

General Information

Please note:

  • This hyperlink was operational at time of referencing this website.
  • The hyperlink will only work when you are "on-line".
  • Information on the Internet changes frequently and this reference relates only to the data drawn down from the internet on the date in the reference suffix (e.g. W1.May00)
Organisation Reference Centers for Disease Control and Prevention (CDC)
Wildpro Referenced Responsibilities:- Conventions, Legislation, Codes of Conduct, Manuals

This web-link has been created as part of the "West Nile Virus " Wildpro volume. Consult the Specific Section References at the end of this page for related links.

The following link connects to the main West Nile virus section:


This information has been taken directly from the Centers for Disease Control and Prevention (CDC) Website:

About CDC

The Centers for Disease Control and Prevention (CDC) is recognized as the lead federal agency for protecting the health and safety of people - at home and abroad, providing credible information to enhance health decisions, and promoting health through strong partnerships. CDC serves as the national focus for developing and applying disease prevention and control, environmental health, and health promotion and education activities designed to improve the health of the people of the United States.

CDC, located in Atlanta, Georgia, USA, is an agency of the Department of Health and Human Services. Dr. Jeffrey P. Koplan is the Director.

CDC's Vision for the 21st Century
Healthy People in a Healthy World – Through Prevention

At CDC, we work hard to make people safer and healthier. By charting decisive courses of action, collecting the right information, and working closely with other health and community organizations, CDC has been putting science into action to tackle important health problems since 1946. With more than 8,500 employees across the country, CDC plays a critical role in protecting the public from the most widespread, deadly and mysterious threats against our health today and tomorrow.

CDC's Mission
To promote health and quality of life by preventing and controlling disease, injury, and disability.

CDC seeks to accomplish its mission by working with partners throughout the nation and world to monitor health, detect and investigate health problems, conduct research to enhance prevention, develop and advocate sound public health policies, implement prevention strategies, promote healthy behaviors, foster safe and healthful environments, and provide leadership and training.

CDC has developed and sustained many vital partnerships with public and private entities that improve service to the American people. In FY 2000, the workforce of CDC comprised approximately 8,500 FTE in 170 disciplines with a public health focus. Although CDC's national headquarters is in Atlanta, Georgia, more than 2,000 CDC employees work at other locations, including 47 state health departments. Approximately 120 are assigned overseas in 45 countries. CDC includes 12 Centers, Institutes, and Offices

CDC Protects Health and Safety

Infectious diseases, such as HIV/AIDS and tuberculosis, have the ability to destroy lives, strain community resources, and even threaten nations. In today's global environment, new diseases have the potential to spread across the world in a matter of days, or even hours, making early detection and action more important than ever. CDC plays a critical role in controlling these diseases, traveling at a moment's notice to investigate outbreaks abroad or at home.

But disease outbreaks are only the beginning of our protective role. By assisting state and local health departments, CDC works to protect the public every day: from using innovative "fingerprinting" technology to identify a foodborne illness, to evaluating a family violence prevention program in an urban community; from training partners in HIV education, to protecting children from vaccine preventable diseases through immunizations.

CDC Provides Credible Information to Enhance Health Decisions

We recognize that the best, most up-to-date health information is meaningless unless it is meaningful and accessible to the people it is meant to serve. By working with public health and grassroots partners, and by leveraging the voices of the internet, and communication media, we ensure the best health and safety information is accessible to the communities and people who need it every day.

CDC Promotes Health through Strong Partnerships

The everyday world provides a series of obstacles to continued good health: pollution and congestion in the air we breathe; contamination in our water supply; unsafe conditions in our daily workplaces. CDC works side by side with national, state and local organizations to help protect communities from dangerous environmental exposures. We may feel secure in our own health. But regardless of how vigilant we might be, the fact remains: in every town, in every community, and in every family, we are vulnerable to hazards in our environment, in our workplace, and even in our home.

CDC alone cannot protect the health of the American people. However, by engaging with others – from state and local health departments to private corporations, from media outlets to the general public – we can achieve our vision of a better world, with safer, healthier people.

Future Challenges

Challenges that CDC faces in the future are highlighted below. CDC's mission and programs clearly focus upon these challenges. 

Improving People's Health by Putting Science into Action
Preventing Violence and Unintentional Injury
Meeting the Health and Safety Needs of a Changing Workforce
Utilizing New Technologies to Provide Credible Health Information
Protecting Individuals against Emerging Infectious Diseases including Bioterrorism
Eliminating Racial/Ethnic Health Disparities
Fostering Safe and Healthy Environments
Working with Partners to Improve Global Health 

CDC Organization

The CDC is one of the major operating components of the Department of Health and Human Services. CDC's major organizational components respond individually in their areas of expertise and pool their resources and expertise on cross-cutting issues and specific health threats. The agency is comprised of these organizational components:

National Center on Birth Defects and Developmental Disabilities (NCBDDD) provides national leadership for preventing birth defects and developmental disabilities and for improving the health and wellness of people with disabilities.

National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) prevents premature death and disability from chronic diseases and promotes healthy personal behaviors.

National Center for Environmental Health (NCEH) provides national leadership in preventing and controlling disease and death resulting from the interactions between people and their environment.

National Center for Health Statistics (NCHS) provides statistical information that will guide actions and policies to improve the health of the American people.

National Center for HIV, STD, and TB Prevention (NCHSTP) provides national leadership in preventing and controlling human immunodeficiency virus infection, sexually transmitted diseases, and tuberculosis.

National Center for Infectious Diseases (NCID) prevents illness, disability, and death caused by infectious diseases in the United States and around the world.

National Center for Injury Prevention and Control (NCIPC) prevents death and disability from non-occupational injuries, including those that are unintentional and those that result from violence.

National Immunization Program (NIP) prevents disease, disability, and death from vaccine-preventable diseases in children and adults.

National Institute for Occupational Safety and Health (NIOSH) ensures safety and health for all people in the workplace through research and prevention.

Epidemiology Program Office (EPO) strengthens the public health system by coordinating public health surveillance; providing support in scientific communications, statistics, and epidemiology; and training in surveillance, epidemiology, and prevention effectiveness.

Public Health Practice Program Office (PHPPO) strengthens community practice of public health by creating an effective workforce, building information networks, conducting practice research, and ensuring laboratory quality.

CDC performs many of the administrative functions for the Agency for Toxic Substances and Disease Registry (ATSDR), a sister agency of CDC, and one of eight federal public health agencies within the Department of Health and Human Services. The Director of CDC also serves as the Administrator of ATSDR.

National Center for Infectious Diseases Division of Vector Borne Infectious Disease



A Brief History

The Division of Vector-Borne Infectious Diseases was established in Logan, Utah, in the 1950s as the Disease Ecology Section of CDC to deal with arboviral encephalitis in the western United States. In 1963, the unit moved to Greeley, Colorado, and in 1967 to its present location in Fort Collins, Colorado. The plague program was moved from San Francisco to the unit at that time. In 1974, the name was changed to the Division of Vector-Borne Viral Diseases. In 1989, the division was given the responsibility of developing a national Lyme disease program and was renamed the Division of Vector-Borne Infectious Diseases to reflect its responsibilities for Lyme disease, plague, and other zoonotic bacterial infections.

What Is the Mission of DVBID?

The Division of Vector-Borne Infectious Diseases serves as a national and international reference center for vector-borne viral and bacterial diseases. As one of the few remaining centers responsible for these agents, it is incumbent on the division to maintain leadership and scientific competence in all major disciplines relating to the field of vector-borne infectious diseases. The mission of the division is to (1) develop and maintain effective surveillance for vector-borne viral and bacterial agents and their arthropod vectors; (2) conduct field and laboratory research and epidemic aid investigations; (3) define disease etiology, ecology, and pathogenesis in order to develop improved methods and strategies for disease diagnosis, surveillance, prevention and control; (4) provide diagnostic reference and epidemiologic consultation, on request, to state and local health departments, other components of CDC, other federal agencies, and national and international health organizations; and (5) provide intramural and extramural technical expertise and assistance in professional training activities. Emphasis is given to laboratory and epidemiologic research to improve diagnosis, surveillance, prevention, and control of diseases of major public health importance such as Lyme disease, dengue/dengue hemorrhagic fever, West Nile virus, yellow fever, arboviral encephalitis, plague, and tularemia. In addition, expertise is maintained for other vector-borne infectious diseases that occur only sporadically or in periodic epidemics.

DVBID Organizational Structure

The organizational structure of DVBID includes three branches that compose the division: the Arbovirus Diseases Branch, the Bacterial Zoonoses Branch, and the Dengue Branch (located in San Juan, Puerto Rico).

Dates Referenced November 2001
Contact Details Centers for Disease Control and Prevention
Public Inquiries/MASO
Mailstop F07
1600 Clifton Road
Atlanta, GA 30333

Telephone Public Inquiries
(404) 639-3534
(800) 311-3435

Website Address




Return to top of page

Specific References (Please note - website addresses change frequently and all references are dated accordingly. If hyperlinks are no longer active, please inform us)

Reference Section of Website Specific Website link
W170.Nov01.WNV1 West Nile Virus Background


W170.Nov01.WNV2 West Nile Virus Questions and Answers


W170.Nov01.WNV3 West Nile Virus Entomology


W170.Nov01.WNV4 West Nile Virus Vertebrate Ecology


W170.Nov01.WNV5 West Nile Virus Virology


W170.Nov01.WNV6 West Nile Virus Surveillance and Control


W170.Nov01.WNV7 West Nile Virus Publications


W170.Nov01.WNV8 Epidemic/Epizootic West Nile Virus in the United States: Revised Guidelines for Surveillance, Prevention and Control 2001
(Full text available)



Morbidity and Mortality Weekly Report

West Nile Virus Activity --- Eastern United States, 2001

July 27, 2001 / 50(29);617-619


W170.Nov01.WNV10 Morbidity and Mortality Weekly Report

Human West Nile Virus Surveillance --- Connecticut, New Jersey, and New York, 2000

April 13, 2001 / 50(14);265-8



Morbidity and Mortality Weekly Report 

Update: West Nile Virus Activity --- Eastern United States, 2000

November 24, 2000 / 49(46);1044-1047 



Morbidity and Mortality Weekly Report 

Update: West Nile Virus Activity --- Northeastern United States, 2000

September 15, 2000 / 49(36);820-2



Morbidity and Mortality Weekly Report

Update: West Nile Virus Activity --- Northeastern United States, January--August 7, 2000

August 11, 2000 / 49(31);714-7




Morbidity and Mortality Weekly Report

West Nile Virus Activity --- New York and New Jersey, 2000

July 21, 2000 / 49(28);640-2



Morbidity and Mortality Weekly Report 

Notice to Readers: Update: West Nile Virus Isolated from Mosquitoes --- New York, 2000

March 17, 2000 / 49(10);211



Morbidity and Mortality Weekly Report

Update: Surveillance for West Nile Virus in Overwintering Mosquitoes --- New York, 2000

March 10, 2000 / 49(09);178-9



Morbidity and Mortality Weekly Report

Guidelines for Surveillance, Prevention, and Control of West Nile Virus Infection -- United States

January 21, 2000 / 49(02);25-8 



Morbidity and Mortality Weekly Report

Update: West Nile Virus Encephalitis -- New York, 1999

October 22, 1999 / 48(41);944-946, 955




Morbidity and Mortality Weekly Report

Update: West Nile-Like Viral Encephalitis -- New York, 1999

October 08, 1999 / 48(39);890-2




Morbidity and Mortality Weekly Report

Outbreak of West Nile-Like Viral Encephalitis -- New York, 1999

October 01, 1999 / 48(38);845-9



W170.Nov01.WNV21 This issue of Emerging Infectious Diseases contains a series of articles on West Nile Virus

Emerging Infectious Diseases Vol. 7, No. 4 Jul–Aug 2001




West Nile Fever–a Reemerging Mosquito-Borne Viral Disease in Europe

Hubálek Z, Halouzka J.

Emerging Infectious Diseases Sep-Oct 1999;5:643-650.


W170.Nov01.WNV23 Migratory Birds and Spread of West Nile Virus in the Western Hemisphere.

Rappole JH, Derrickson SR, Hubálek Z. 

Emerging Infectious Diseases Jul-Aug 2000;6:319-328.


W170.Nov01.WNV24 National West Nile Virus Surveillance System, 2000: Final Plan


W170.Nov01.WNV25 Guidelines for Arbovirus Surveillance in the United States 1993
(Full text available)



W170.Nov01.WNV26 CDC Data and Specimen Handling (DASH) section form 50.34 for submission of laboratory specimens


W170.Nov01.WNV27 Mosquitoes of Public Health Importance and Their Control. Self-Study Course 3013-G, Vector-Borne Disease Control:

Pages 1-13

Pages 14-21

Pages 22-44

Pages 45-57

Pages 58-74

Pages 75-85


This is a miscellaneous document referenced within Wildpro as D70



http://www.cdc.gov/ncidod/dvbid/westnile/resources/mos_p22_p44.pdf http://www.cdc.gov/ncidod/dvbid/westnile/resources/mos_p45_p57.pdf

http://www.cdc.gov/ncidod/dvbid/westnile/resources/mos_p58_p74.pdf http://www.cdc.gov/ncidod/dvbid/westnile/resources/mos_p75_p85.pdf


CDC Office of Communication Media Relations

Update : West Nile Virus


W170.Nov01.WNV29 Links to State and Government Sites


W170.Nov01.WNV30 West Nile Virus Other Related Sites


W170.Nov01.WNV31 West Nile Virus CDC Slide Presentations


W170.Nov01.WNV32 West Nile Virus:
Avoid Mosquito Bites to Avoid Infection


W170.Nov01.WNV33 Related Resources State Health Departments


W170.Nov01.WNV34 Map: The Geographic Distribution of the Japanese Encephalitis Serocomplex of the Family, Flaviviridae, 2000


W170.Nov01.WNV35 Rabies Homepage


W170.Nov01.WNV36 Rabies Introduction


W170.Nov01.WNV37 Rabies The Virus


W170.Nov01.WNV38 Rabies Natural History


W170.Nov01.WNV39 Rabies Diagnosis


W170.Nov01.WNV40 Rabies Epidemiology


W170.Nov01.WNV41 Rabies Prevention and Control


W170.Nov01.WNV42 Rabies Questions and Answer


W170.Nov01.WNV43 Bats and Rabies 


W170.Nov01.WNV44 Epidemic Information Exchange (Epi-X)  http://www.cdc.gov/programs/research5.htm
W170.Nov01.WNV45 National Electronic Telecommunications System for Surveillance  http://www.cdc.gov/epo/dphsi/netss.htm
W170.Nov01.WNV46 National Electronic Disease Surveillance System http://www.cdc.gov/od/hissb/act_int.htm
W170.Aug02.WNV1 West Nile Virus (WNV) Infection Information for Clinicians-August 20, 2002 http://www.cdc.gov/ncidod/dvbid/westnile/resources/fact_sheet_clinician.htm
W170.Aug02.WNV2 Links to State and Local Government Sites http://www.cdc.gov/ncidod/dvbid/westnile/city_states.htm
W170.Sept02.H1 African pygmy hedgehog-associated salmonellosis -- Washington, 1994 http://www.cdc.gov.mmwr/preview/mmwrhtml/00038010.htm
W170.Sept02.WNV1 Morbidity and Mortality Weekly Report

Acute Flaccid Paralysis Syndrome Associated with West Nile Virus Infection - Mississippi and Louisiana, July-August 2002

September 20, 2002 / 51 (37); 826-828

See: N7.51.w1

W170.Sept02.WNV2 Morbidity and Mortality Weekly Report

West Nile Virus Infection in Organ Donor and Transplant Recipients - Georgia and Florida, 2002

September 6, 2002 / 51 (35); 790

See: N7.51.w2

W170.Sept02.WNV3 Morbidity and Mortality Weekly Report

Update: Investigations of West Nile Virus Infections in Recipients of Organ Transplantation and Blood Transfusion

September 20, 2002 / 51 (37); 833-836

See: N7.51.w3

W170.Oct02.WNV1 Morbidity and Mortality Weekly Report

Possible West Nile Virus Transmission to an Infant Through Breast-Feeding - Michigan, 2002

October 4, 2002 / 51 (39); 877-878

See: N7.51.w4



W170.Nov02.WNV1 Morbidity and Mortality Weekly Report

Investigations of West Nile Virus Infections in Recipients of Blood Transfusions

November 1, 2002 / 51 (43); 973-974

See: N7.51.w5

W170.Dec02.WNV1 Morbidity and Mortality Weekly Report

Provisional Surveillance Summary of the West Nile Virus Epidemic - United States, January-November 2002

December 20, 2002 / 51(50);1129-1133

See: N7.51.w6

W170.Dec02.WNV2 Morbidity and Mortality Weekly Report

Laboratory-Acquired West Nile Virus Infections - United States, 2002

December 20, 2002 / 51(50);1133-1135

See: N7.51.w7

W170.Dec02.WNV3 Morbidity and Mortality Weekly Report

Intrauterine West Nile Virus Infection - New York, 2002

December 20, 2002 / 51(50);1135-1136

See: N7.51.w8

W170.07Jul03.WNV1 West Nile Virus 2003 Human Cases [Accessed 07 July 2003] http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03.htm
W170.25Jul03.WNV1 West Nile Virus - Mosquito Species http://www.cdc.gov/ncidod/dvbid/westnile/mosquitoSpecies.htm
W170.19Jan04.WNV1 West Nile Virus 2003 Human Cases as of January 14, 2004, 3am MST [Accessed 19 January 2004] http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03.htm
W170.28Jan04.WNV1 Encephalitis or Meningitis, Arboviral (includes California serogroup, Eastern equine, St. Louis, Western equine, West Nile, Powassan)
2001 Case Definition
W170.16Jun04.R1 About Rabies http://www.cdc.gov/ncidod/dvrd/rabies/introduction/intro.htm
W170.16Jun04.R2 The Rabies Virus http://www.cdc.gov/ncidod/dvrd/rabies/the_virus/virus.htm
W170.16Jun04.R3 Natural History http://www.cdc.gov/ncidod/dvrd/rabies/natural_history/nathist.htm
W170.16Jun04.R4 Diagnosis http://www.cdc.gov/ncidod/dvrd/rabies/diagnosis/diagnosi.htm
W170.16Jun04.R5 Epidemiology http://www.cdc.gov/ncidod/dvrd/rabies/Epidemiology/Epidemiology.htm
W170.16Jun04.R6 Prevention and Control http://www.cdc.gov/ncidod/dvrd/rabies/prevention&control/preventi.htm
W170.16Jun04.R7 Bats & Rabies http://www.cdc.gov/ncidod/dvrd/rabies/bats_&_rabies/bats&.htm
W170.05Sept04.R1 Protocol for Postmortem Diagnosis of Rabies in Animals by Direct Fluorescent Antibody Testing A Minimum Standard for Rabies Diagnosis in the United States http://www.cdc.gov/ncidod/dvrd/rabies/Professional/publications/
W170.07Nov05.W1 NIOSH ALERT Preventing Allergic Reactions to Natural Rubber Latex in the Workplace  http://www.cdc.gov/niosh/latexalt.html
W170.12May08.wnv1 2003 West Nile Virus Activity in the United States http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03
W170.12May08.wnv2 2004 West Nile Virus Activity in the United States http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount04
W170.12May08.wnv3 2005 West Nile Virus Activity in the United States http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount05
W170.12May08.wnv4 2006 West Nile Virus Activity in the United States http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount06
W170.12May08.wnv5 2007 West Nile Virus Activity in the United States http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount07
W170.12May08.wnv6 Neuroinvasive and Non-Neuroinvasive Domestic Arboviral Diseases 2004 Case Definition [See D344 - full text included] http://www.cdc.gov/ncphi/disss/nndss/casedef/arboviral_current.htm
W170.25May08.w1 Map: Geographic Distribution of the Japanese Encephalitis Serocomplex of the Family Flaviridae, 2000 http://www.cdc.gov/ncidod/dvbid/westnile/map.htm
W170.25Oct2012 Hantavirus Pulmonary Syndrome (HPS) Case Definition http://www.cdc.gov/hantavirus/health-care-workers/hps-case-definition.html

Return to top of page